Navigation Links
American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications
Date:6/4/2009

dosing of cyclosporine is given as 2.5 mg/kg to 5.0 mg/kg a day in two divided doses, and physicians should make decreased dose adjustments by 0.5 mg/kg to 1.0 mg/kg when psoriasis is cleared or when high blood pressure or decreased kidney function test results are observed.

Toxicities & Contraindications

The most serious side effects associated with cyclosporine are kidney damage and high blood pressure, which is why it requires careful patient selection and subsequent monitoring to be used safely. A number of drug interactions can occur with this medication, and the FDA advises that it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

"Studies also show that patients with psoriasis taking cyclosporine may be at increased risk of developing squamous cell carcinoma, particularly those with a history of more than 200 PUVA treatments," said Dr. Pariser. "Due to these known toxicities and contraindications, a careful assessment of a psoriasis patient's disease severity is critical when assessing the risk-benefit ratio of treatment with cyclosporine."

Acitretin

Acitretin is an oral retinoid, which is derived from vitamin A. Although the exact way retinoids work in the treatment of psoriasis is not completely understood, they are known to inhibit excessive cell growth and stimulate differentiation of the epidermis (outermost layer of the skin). Etretinate was the first retinoid introduced for the treatment of severe psoriasis and was replaced by acitretin, the active metabolite of etretinate, in 1988.

Efficacy & Dosage

Clinical studies suggest that when used alone, acitretin is the least effective of the traditional systemic therapies and is therefore often used in conjunction with ultraviolet (UV) light. The effectiveness of acitretin is dose dependent, with dosing ranging from 10 mg to 5
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Amercanex, the American Cannabis Exchange, today ... Amercanex’s new Chief Technology Officer. Amercanex is the ... wholesale distributors and retail vendors can buy, sell, ... intra-state market. , Jim Miller is an accomplished ... helping innovative technology companies deliver on their business ...
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... SB 277 (CA Legislature, bit.ly/1Q0P8OY) will require ... public or private school. SB277 cleared three Senate policy ... Committee (Sacramento Bee, May 11, 2015, bit.ly/1Gh9jU7). It passed ... “We believe that this bill affects the education of ... will (the) affect public health of California.. It is ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Lynn Lester as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... honor Lynn Lester with this prestigious award,” said NAPW ...
(Date:6/1/2015)... 2015 The National Association of ... 2015-2016 inductee into its VIP Woman of the ... distinction for leadership in business. NAPW is the ... boasting more than 700,000 members and over 200 ... Kathy into this exceptional group of professional women,” ...
Breaking Medicine News(10 mins):Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2
... , WASHINGTON , Feb. 17 ... his role in organizing a Detroit -area home health care ... the Criminal Division; U.S. Attorney for the Eastern District of Michigan ... the FBI,s Detroit Field Office; and Special Agent in Charge Lamont ...
... language paid attention to both, study found, , WEDNESDAY, ... languages spoken regularly during pregnancy might encourage babies to ... new study finds. , A team of psychological scientists ... Organization for Economic Cooperation and Development in France, watched ...
... the University of Cincinnati Neuroscience Institute (UCNI) at ... medication to prevent seizures in patients who have ... stroke. This randomized study supports earlier indications ... was as effective at preventing seizures as the ...
... Nurses who provide telephone advice services have to balance ... acting as a gatekeeper to limited healthcare services, according ... Journal of Advanced Nursing . Canadian ... two decades, covering more than 700 nurses in the ...
... ... in most specialties a unique cultural exchange at top-tier hospitals and medical facilities in the ... ... Staffing (GMS) announced that it has contracted with a group of top-tier hospitals and medical ...
... ... launched a new health education program to promote sound “mind and body” health practices ... ... National Alliance on Mental Illness ( NAMI ) has launched a new health education ...
Cached Medicine News:Health News:Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme 2Health News:Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme 3Health News:Bilingualism Might Begin in the Womb 2Health News:Study supports alternative anti-seizure medication following acute brain injury 2Health News:Study supports alternative anti-seizure medication following acute brain injury 3Health News:Study supports alternative anti-seizure medication following acute brain injury 4Health News:Telenurses face conflict between what is best for patients and what services are available 2Health News:Telenurses face conflict between what is best for patients and what services are available 3Health News:Global Medical Staffing Extends Locum Tenens Physician Placement to the Middle East 2Health News:“Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans, 2Health News:“Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans, 3Health News:“Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans, 4Health News:“Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans, 5
(Date:6/2/2015)... June 2, 2015 ... mejora  de 7,9 meses en la supervivencia libre ... con cáncer colorrectal metastático inoperable (mCRC) tratados  en ... Y-90 más quimioterapia    Los beneficios ... directamente al hígado con la quimioterapia sistémica actual ...
(Date:6/1/2015)... June 2, 2015 Amgen (NASDAQ: ... on a Phase 1b study to evaluate the ... oncolytic immunotherapy, in combination with Roche,s investigational anti-PDL1 ... with triple-negative breast cancer and colorectal cancer with ... investigational oncolytic immunotherapy designed to selectively replicate in ...
(Date:6/1/2015)... , June 1, 2015   Regulus Therapeutics ... company leading the discovery and development of innovative ... G. Xanthopoulos , Ph.D. has resigned as President ... of Regulus, Board of Directors, effective today, to ... Grint, M.D., who previously served as Chief Medical ...
Breaking Medicine Technology:Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... a basic Peripheral Nerve Locator only, which ... location during regional anesthesia. Ideal for day ... constant current NS232, NS252, NS272 PNS are ... programmed. ,Hand-held, battery operated, and includes automatically ...
Pocket-size digital nerve locator optimizes ease and convenience of performing peripheral nerve blocks. Includes RBW-5L electrode lead set, 9V alkaline battery, and durable molded polyethylene carryi...
Single cuff electronic tourniquet....
The Lone Star Retractor System may be adapted to a specific region of the anatomy by simply adjusting the hinges. The system also includes multiple ring shapes, slots on perifephery of retractor ring...
Medicine Products: